News archive
335 results
2024 annual report on the supervision of the quality and safety of substances of human origin has been published
Cross-border ePrescription is perceived to improve access to medicines, tools are needed for patient counselling to improve medication safety
Mesalazine-containing enteric-coated tablets are in short supply
Registration open for Fimea’s NIS2 entity list
New designer drugs to be subject to control
Cybersecurity Act enters into force - new regulation for operators
Fimea organises a Horizon Scanning event for pharmaceutical companies 16th of May
The Nordic Council of Ministers’ Blood, Tissue and Cell Working Group to meet in Helsinki
Johanna Seppänen appointed Director of Development and Information Services at Fimea
Fimea’s final accounts and annual report for 2024 have been published
Extension to the scope of the Finnish notified body
The process of developing the National High-Risk Medicines Classification is described in an international article
European Medicines Agency’s monitoring platform for shortages is now in use – training available for marketing authorisation holders
Language versions of the patient engagement checklist in research published
High-Risk Medicines Classification of cancer drugs is now under way
The labelling of the expiry date on certain veterinary packages to be allowed in the format dd/mm/yyyy
Change in fees related to mandatory reserve supply permits as of 1 January 2025
Nitrofur-C 75 mg tablets to be withdrawn from the market in 2025
Finnish statistics on medicines 2023 has been published
Requirements of the EU F-gas regulation for placing on the market and import of metered dose inhalers containing HFC propellants
Showing 1 - 20 / 335
